These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1245 related items for PubMed ID: 9803585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, Neira M, Ivanoff B.
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [Abstract] [Full Text] [Related]

  • 3. Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis.
    Naficy A, Rao MR, Paquet C, Antona D, Sorkin A, Clemens JD.
    JAMA; 1998 Feb 18; 279(7):521-5. PubMed ID: 9480362
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral cholera vaccine--for whom, when, and why?
    Topps MH.
    Travel Med Infect Dis; 2006 Jan 18; 4(1):38-42. PubMed ID: 16887724
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
    Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, Puri M, Ali M, Ansaruzzaman M, Amos J, Macuamule A, Cavailler P, Guerin PJ, Mahoudeau C, Kahozi-Sangwa P, Chaignat CL, Barreto A, Songane FF, Clemens JD.
    N Engl J Med; 2005 Feb 24; 352(8):757-67. PubMed ID: 15728808
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral vaccines for cholera control.
    Chaturvedi S, Chaturvedi S.
    Natl Med J India; 1997 Feb 24; 10(1):17-8. PubMed ID: 9069701
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea.
    Lundkvist J, Steffen R, Jönsson B.
    J Travel Med; 2009 Feb 24; 16(1):28-34. PubMed ID: 19192125
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
    Khan AI, Levin A, Chao DL, DeRoeck D, Dimitrov DT, Khan JAM, Islam MS, Ali M, Islam MT, Sarker AR, Clemens JD, Qadri F.
    PLoS Negl Trop Dis; 2018 Oct 24; 12(10):e0006652. PubMed ID: 30300420
    [Abstract] [Full Text] [Related]

  • 16. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.
    Chowdhury MI, Sheikh A, Qadri F.
    Expert Rev Vaccines; 2009 Dec 24; 8(12):1643-52. PubMed ID: 19943759
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique.
    Cavailler P, Lucas M, Perroud V, McChesney M, Ampuero S, Guérin PJ, Legros D, Nierle T, Mahoudeau C, Lab B, Kahozi P, Deen JL, von Seidlein L, Wang XY, Puri M, Ali M, Clemens JD, Songane F, Baptista A, Ismael F, Barreto A, Chaignat CL.
    Vaccine; 2006 May 29; 24(22):4890-5. PubMed ID: 16298025
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 63.